Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Aequus Pharmaceuticals Logo
Aequus Pharmaceuticals Growth Score
32
CB Rank
225950
Heat Score
36
Aequus Pharmaceuticals is a pharmaceutical company that focuses on therapeutic areas, including neurology, ophthalmology, and transplant.
Founded
obfuscation
PublicPost-IPO Debt Vancouver, British Columbia, Canada11-50 aequuspharma.ca/
Consumer
Health Care
Pharmaceutical
Overview

Aequus Pharmaceuticals
Total Funding
obfuscation
Growth Score
32
Heat Score
36

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score32
-5 pts
in past quarter
Heat Score 36
1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Aequus Pharmaceuticals

CB Rank
225950
Aequus Pharmaceuticals is a pharmaceutical company that focuses on therapeutic areas, including neurology, ophthalmology, and transplant.
Founded
obfuscation
PublicPost-IPO Debt Vancouver, British Columbia, Canada11-50 aequuspharma.ca/
Consumer
Health Care
Pharmaceutical

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation

Key People

Details

Legal Name Aequus Pharmaceuticals Inc.
Operating Status Active
Stock Symbol  CVE:AQS
Company Type For Profit
Founders  Doug Janzen
About the Company

Aequus Pharmaceuticals Inc. is a Vancouver-based company, focused on enhancing delivery methods for approved drugs and select consumer products that are limited by non-compliance, high frequency dosing, first-pass metabolism side effects, painful injections, or where the commercial presentation can be improved by making a long acting alternative

available.

Phone Number (604) 428-4641
Contact Email info@aequuspharma.ca
Predictions & Insights

Products & Services

ZIMED® PF
A preservative-free ophthalmic solution containing bimatoprost 0.03% for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
AQS1303 Transdermal Anti-Nausea Patch
A long-acting transdermal patch delivering pyridoxine and doxylamine to treat nausea and vomiting of pregnancy as an alternative to oral medication.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Aequus Pharmaceuticals Logo
Post-IPO Debt - Aequus Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Aequus Pharmaceuticals Logo
Post-IPO Debt - Aequus Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Aequus Pharmaceuticals Logo
Post-IPO Debt - Aequus Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Aequus Pharmaceuticals Logo
Post-IPO Debt - Aequus Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Aequus Pharmaceuticals Logo
Post-IPO Debt - Aequus Pharmaceuticals
—
obfuscation
— Post-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Aequus Pharmaceuticals Logo
Post-IPO Debt - Aequus Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Aequus Pharmaceuticals Logo
Post-IPO Debt - Aequus Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Aequus Pharmaceuticals Logo
Post-IPO Debt - Aequus Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Aequus Pharmaceuticals Logo
Post-IPO Debt - Aequus Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Aequus Pharmaceuticals Logo
Post-IPO Debt - Aequus Pharmaceuticals
—
obfuscation
— Post-IPO Debt

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Contacts 10

Employee Profiles

News

News and Press

News•Apr 25, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 9, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 19, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 26, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

771

IT Spend

$3.4KThis year, Aequus Pharmaceuticals is projected to spend $3.4K on IT, according to Aberdeen.

Active Website Tech Count

7Aequus Pharmaceuticals is actively using 7 technologies for its website, according to BuiltWith. These include CommonCrawl Top 10m, IIS 10, and  Google Universal Analytics.

Total IP

3The intellectual property of Aequus Pharmaceuticals includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Aequus Pharmaceuticals's headquarters? Aequus Pharmaceuticals is located in Vancouver, British Columbia, Canada.Who invested in Aequus Pharmaceuticals? Aequus Pharmaceuticals is funded by Northview LifeSciences.When was the last funding round for Aequus Pharmaceuticals? Aequus Pharmaceuticals closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Aequus Pharmaceuticals's competitors? Alternatives and possible competitors to Aequus Pharmaceuticals may include Lumira Ventures, Teva Pharmaceuticals, and  Aa Pharma.How much funding has Aequus Pharmaceuticals raised to date? Aequus Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(886b565 1)
|